OOIR: Observatory of International Research

Papers

(The median citation count of International Journal of Tuberculosis and Lung Disease is 1. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2021-03-01 to 2025-03-01.)

Article	Citations
Alcohol use disorder and TB survivor health	178
Bedaquiline exposure in people with drug-resistant TB treated for diabetes: analysis of two phase 2 trials	86
Occupational safety and health for respiratory health: a comprehensive approach for an often-forgotten issue	78
An Inca trail to the Holy Grail: digital medication adherence support for TB care	37
Aspergillus infection is an important complication of post-TB bronchiectasis	36
Quality assessment of clinical practice guidelines for the management of wheezing disorders in children	34
Response to: The pressing need for standardised diagnostic criteria for obstructive ventilatory impairment in adults and children	34
A home-based care programme for rifampicin-resistant TB	30
A cross-sectional study of risk factors for TB among socially marginalised people	29
After DOT, the brave new world?	24
COVID-19 effect on TB presentation and outcome	23
Low serum levels of anti-TB drugs in a high TB setting	23
TB diagnosis and treatment during the COVID-19 pandemic	22
A large cohort study of TB of the central nervous system: clinical outcomes	20
TB preventive treatment in high- and intermediate-incidence countries: research needs for scale-up	20
Screening for TB infection: the operator´s impact	20
Establishing proof of concept for utility of Trueprep^®-extracted DNA in line-probe assay testing	20
Isoniazid-resistant TB: treatment outcomes and impact of regimens with fluoroquinolones	19
The cascade of care for household contacts of people with drug-resistant TB	18
Literature Highlights	18
Use of interactive messaging to reduce pre-diagnosis loss to follow-up for TB care	18
Is a high dose sufficient to achieve high isoniazid exposure in children affected by multidrug-resistant TB?	17
Tackling the many layers of stigma is essential for the “End TB Strategy”	17
Dactylitis due to accidental needle-stick injury with a BCG-loaded syringe	16
TB screening, prevention and treatment cascade in a Malawi prison	15

A study of persistent symptoms and pulmonary function at 3 months post moderate or severe COVID-19 in Angola	15
Active case-finding of pulmonary TB in an urban emergency department	15
Shorter regimens for multidrug-/rifampicin-resistant TB	14
Chest X-ray scoring to screen for chronic pulmonary aspergillosis in patients with a history of pulmonary TB	13
Targeted TB control in migrants to low-burden countries	13
Reducing the burden of TB among migrants to low TB incidence countries	13
Flupentixol/melitracen for chronic refractory cough after treatment failure with other neuromodulators	13
Clinical profile and outcomes of paediatric central nervous system tuberculomas	12
The impact of sputum quality on Xpert positivity in active case-finding for TB	12
The absence of evidence of cure is not a risk for recurrent TB among patients treated for TB	11
Digital medication adherence technology: towards personalised TB care	11
High mortality due to gastrointestinal TB in HIV and non-HIV patients	11
Prevalence of tobacco smoking and cannabis use in young men in South Africa	11
Improving enrolment for TB preventive treatment	11
Dr Christopher Zishiri	11
Travel reimbursements, distance to health facility and preventive treatment cascade for drug-resistant TB	11
Reply to ‘Estimating TB survival ‐ mind the immortal-time gap’	10
Armand Van Deun ‐ pioneering public health physician (1953–2023)	10
QT prolongation in the STREAM Stage 1 Trial	10
Anti-tuberculosis activity of morusin: a promising flavonoid from white mulberry	10
Literature Highlights	10
Two-year follow-up of 196 interstitial lung disease patients after ICU stay	10
Geographical differences in chronic obstructive pulmonary disease mortality trends by sex, Spain, 1980–2021	10
QTc prolongation with bedaquiline treatment for drug-resistant pulmonary TB in a programmatic setting	10
A bold new future for the IJTLD	10
Post-TB lung disease in three African countries	9
Detection of Mycobacterium tuberculosis cell-free DNA to diagnose TB in pediatric and adult patients	9
Evidence and ethical considerations for the treatment of contacts exposed to drug-resistant TB	9
High-dose proton pump inhibitors are associated with hospitalisation in bronchiectasis exacerbation	9
The impact of COVID-19 on the TB response: data from the field	9
Family directly observed therapy for children with drug-resistant TB	9
Decline in TB incidence during the COVID-19 pandemic	8
Efflux pump gene expression study using RNA-seq in multidrug-resistant TB	8
Limitations of using tuberculin skin test to screen for TB in patients with psoriasis	8
Impact of the bacillary load on the accuracy of rifampicin resistance results by Xpert^® MTB/RIF	8
TB in ageing populations: lessons from Japan and Korea	8
An epidemiological analysis of TB trends in native and migrant populations, New Mexico, 1993–2021	8
The impact of the COVID-19 pandemic on TB in a low TB burden setting	8
Did public-private partnerships reduce TB incidence in Korea?	8
Incidence of tuberculous infection in a TB-endemic city	8
The effect of antenatal isoniazid preventive therapy on birth outcomes in Western Kenya	7
Metabolic characterisation of adult Ugandan patients with TB and diabetes mellitus comorbidity	7
Clinical standards for drug-susceptible TB: putting patients first	7
Accelerating TB diagnosis during the COVID-19 pandemic	7
Atorvastatin to reduce bacillary load and attenuate lung damage in TB patients	7
Management of childhood MDR-TB in Europe and Central Asia: report of a Regional WHO meeting	7
TB-related deaths among adults in Guinea-Bissau	7
WHO target product profiles for TB preventive treatment	7
Chronic pulmonary aspergillosis: a neglected post-TB lung disease	7
Does BCG vaccination protect against infection with M. tuberculosis?	7

Lessons learned from treating drug-resistant TB and how to apply these to drug-susceptible TB	7
Early line-probe assay using DNA specimens in patients with pulmonary TB	7
Use of local data to evaluate TB contact investigation in Malawi	6
Impact of the COVID-19 pandemic on TB infection testing	6
Extrapulmonary TB: a 30-year observational study of an Italian cohort	6
Factors associated with presenting to private sector care providers at the onset of TB symptoms	6
Ultrasound-guided lymph node biopsy in smear-negative children and adolescents with suspected TB	6
Assessment of TB treatment on patient well-being	6
Launch of a second wave of IJTLD Clinical Standards for Lung Health	6
Costs of treating multidrug-resistant TB in California in 2022	6
Non-malignant occupational respiratory diseases and climate change	6
TB and COVID-19 in migrants – the need to focus on both conditions	6
Approaches and processes for paediatric chest X-ray classification used in the SHINE TB treatment-shortening trial	6
Clinical characteristics and decortication outcomes of bacterial, tuberculous and fungal pleural infection	6
Treatment outcomes and predictive factors for multidrug-resistant TB and HIV coinfection in Rio de Janeiro State, Brazil	5
Pretomanid with bedaquiline and linezolid for drug-resistant TB: a comparison of prospective cohorts	5
Treatment outcomes of multidrug-resistant TB with selective use of new drugs	5
Pulmonary TB and chronic pulmonary aspergillosis	5
Clinical and imaging features of drug-susceptible and multidrug-resistant TB in Korean adults	5
Latent TB and depressive symptoms in household contacts of persons with active TB	5
Predictors of mortality in Ugandan children with TB, 2016–2021	5
Ethambutol-induced optic neuropathy: should we mandate ophthalmic examination in TB treatment?	5
Stool testing for pulmonary TB diagnosis in adults	5
Screening for active and latent TB among migrants in France	5
Use of a molecular bacterial load assay to distinguish between active TB and post-TB lung disease	5
Smoked drug use in patients with TB is associated with higher bacterial burden	5
Current status and future prospects of TB digital treatment adherence technology use in China	5
A systematic review of the costs of diagnosis for multidrug-resistant/extensively drug-resistant TB in different settings	5
Diabetes mellitus and TB – finding strategies to reduce the double burden of disease	5
Risk factors for TB in Australia and their association with delayed treatment completion	5
Implementation of modified, all-oral shorter TB regimens in Armenia	5
Cost-effectiveness of pretomanid-based regimen for highly drug- resistant TB in a low-burden setting	5
Screening of refugees from Ukraine for TB: a TBnet survey	5
Diagnosis of paediatric TB using Xpert^® MTB/RIF Ultra on fresh respiratory samples	5
Low BMI increases all-cause mortality rates in patients with drug-resistant TB	5
Incidence of TB disease among persons who use drugs in California	5
Differences in gender perception of smokeless tobacco	5
Decentralising DOT for drug-susceptible TB from the health facilities to the community level in Togo	5
Surgical treatment for non-tuberculous mycobacterial pulmonary disease: analysis of prognostic factors	5
Impact of Rv0678 mutations on patients with drug-resistant TB treated with bedaquiline	4
Advantages and limitations of virtual multi-disciplinary team meetings on difficult-to-treat mycobacteria	4
Obstructive sleep apnoea in the elderly: a significant problem that needs urgent attention	4
Chronic pulmonary aspergillosis in patients with post-TB sequelae	4
Multigene Mycobacterium tuberculosis cell-free DNA assay	4
TB outpatient care in a high-income, low-incidence country	4
Diagnostic accuracy of an exhaled breath test for TB in hospitalized patients with cough or risk	4
Improving access to affordable quality-assured inhaled medicines in low- and middle-income countries	4
The Asthma Drug Facility and the future management of asthma	4
Recent developments in the diagnosis and treatment of extrapulmonary non-tuberculous mycobacterial diseases	4
Prevalence of and risk factors for depressive symptoms in non-tuberculous mycobacterial pulmonary disease	4
Co-administration of treatment for drug-resistant TB and hepatitis C	4
Favourable outcomes in RR-TB patients using BPaL and other WHO-recommended second-line anti-TB drugs	4
Occupational transmission of TB infection during autopsy	4
A non-invasive, sensitive assay for active TB: combined cell-free DNA detection and FluoroSpot assays	4
Targeted therapeutic drug monitoring identifies frequent under-dosing of TB drugs	4
Outdoor air pollution and respiratory health	4
The rise of artificial intelligence reading of chest X-rays for enhanced TB diagnosis and elimination	4
A partially randomised trial of pretomanid, moxifloxacin and pyrazinamide for pulmonary TB	4
CAD4TB software updates: different triaging thresholds require caution by users and regulation by authorities	4
Early mortality during rifampicin-resistant TB treatment	4
Diurnal variability of fine-particulate pollution concentrations: data from 14 low- and middle-income countries	4
An effective vaccine is only the first step: the need to create and sustain demand for TB vaccines	4
TB testing in HIV-positive patients prior to antiretroviral treatment	4
Comparison of pharmacokinetics and bioavailability of bedaquiline fumarate, benzoate and maleate in dogs	4
Indoor pet allergen exposures modify the effects of chemical air pollutants on respiratory symptoms	4
Performance of the DECAF score in predicting hospital mortality due to acute exacerbations of COPD	4
Xpert^® MTB/RIF Ultra: detection of extrapulmonary TB in a high-burden setting	4
Clinical standards for the diagnosis, treatment and prevention of TB infection	4
Therapeutic strategies and outcomes of MDR and pre-XDR-TB in Italy: a nationwide study	4
TB infection in adults with diabetes mellitus in Uganda	4
Diagnosing pulmonary aspergillosis is much easier than it used to be: a new diagnostic landscape	4
Diagnosis patterns for rifampicin-resistant TB after onset of COVID-19	4
Community-based TB testing as an essential part of TB recovery plans in the COVID-19 era	4
Health-related quality of life associates with clinical parameters in patients with NTM pulmonary disease	4
A novel home-based method for preparing suspensions of anti-TB drugs	3
Are schools prepared to manage students with an asthma attack?	3
Screening with GenoType^® MTBDRplus shortens the time to MDR-TB treatment initiation but does not change outcomes	3
Risk factors in ICU patients with initial acquisition of carbapenemase-resistant Klebsiella Pneumoniae	3
Use of rapid molecular TB diagnostics for incarcerated people in Brazil	3
Assessing patient satisfaction with video-supported therapy for drug-susceptible TB treatment	3

Travel history and challenges of screening for latent TB infection in child asylum seekers	3
Impact of lung function on treatment outcome in patients with TB	3
Measuring cough-related quality of life and cough frequency in pulmonary TB	3
Geographic mobility and time to seeking care among people with TB in Limpopo, South Africa	3
The timing of intravenous antibiotics and clinical outcomes of Mycobacterium abscessus complex lung diseases	3
Source case investigation can reduce the diagnostic gap for childhood TB	3
T-SPOT.TB performed in lymphnodal tissue for the diagnosis of lymphadenitic TB	3
Impact of revised definitions for extensively drug-resistant TB on disease classification	3
Acquired bedaquiline resistance in Karakalpakstan, Uzbekistan	3
Using a mobile application to improve pediatric presumptive TB identification in western Kenya	3
Miliary TB in children and adolescents: a scoping review	3
Air conditioners, airborne infection prevention and air pollution in buildings in New Delhi	3
Prevalence, knowledge and factors associated with shisha smoking among university students in Cameroon	3
Performance of spirometry assessment at TB diagnosis	3
TB infection in healthcare workers – the reality of a Portuguese hospital	3
Adequacy of WHO weight-band dosing and fixed-dose combinations for the treatment of TB in children	3
Persistent chronic respiratory symptoms despite TB cure is poorly correlated with lung function	3
Perceived stigma among people with TB and household contacts	3
Finding TB´s “missing millions”, one district at a time	3
Feasibility and acceptability of asynchronous VOT among patients with MDR-TB	3
Decreasing time spent in airborne infection isolation during TB testing	3
A roadmap for lifting restrictive measures for COVID-19	3
Private pharmacy and community health worker engagement in the provision of TB services	3
Randomised-controlled trials and real-world evidence for optimising TB management	3
Haematological indicators of mortality in people with community-acquired pneumonia living at high altitude	3
Interventions to enhance treatment adherence and retention in care for HIV-TB	3
Unhealthy alcohol use independently associated with unfavorable TB treatment outcomes among Indian men	3
Programmatic implications of a sub-national TB prevalence survey in India	3
Pulmonary and pleural TB prevalence in pregnant women	3
Effectiveness of GenoType MTBDRsl in excluding TB drug resistance in a clinical trial	3
Why TB programmes should assess for comorbidities, determinants and disability at the start and end of TB treatment	3
Compliance with new drug use and the effect of discrepant drug susceptibility testing on MDR/RR-TB treatment	3
Hospitalizations with TB, California, 2009–2017	3
Literature Highlights	3
Caregiver willingness to give TPT to children living with drug-resistant TB patients	3
Reply to: Observations on malnutrition and anti-TB drugs in Ghana	3
Iqbal Haroon Master, 1962–2021	3
Introduction of the Simple One-Step stool Xpert Ultra method to detect TB in children and adults	3
Management of suspected hypersensitivity reactions to anti-TB drugs	3
Infection status of contacts is not associated with severity of TB in the index case	3
Whole-genome sequencing for TB source investigations: principles of ethical precision public health	3
Age-period-cohort analysis of TB mortality in South Korea, 1983–2017	3
Primary bedaquiline resistance in Karakalpakstan, Uzbekistan	3
The hidden burden of miliary TB in children and adolescents	3
Household air pollution and COPD: cause and effect or confounding by other aspects of poverty?	3
National survey on the impact of the war in Ukraine on TB diagnostics and treatment services in 2022	3
Trends in TB and HIV care and treatment cascade, Kenya, 2008–2018	3
Bridging the gap: key evidence needed to strengthen global policies to end TB	3
The importance of pharmacokinetics/pharmacodynamics assessment in Phase IIB/III trials for MDR-TB treatment	2
Planning for TB elimination in Lebanon	2
Compliance of vendors with legislation restricting the sale of tobacco near educational institutions in India	2
Stool-based Xpert testing for diagnosis of TB in children and critically ill adults	2
Outcomes of WHO-conforming, longer, all-oral multidrug-resistant TB regimens and analysis implications	2
Nirmatrelvir/ritonavir and pharmacovigilance data	2
Tackling TB in Europe: treatment gaps and deteriorating treatment availability is undermining progress	2
Incidence of TB among kidney transplant recipients in a setting with universal isoniazid prophylaxis	2
Thrombotic events and COVID-19 vaccines	2
An update on the IJTLD: our latest impact factor and influence on policy-making	2
Impact of COVID-19 on TB detection in the private sector in Nepal	2
Clinical outcomes in comorbid COVID-19 and TB cases	2
Sputum culture conversion definitions and analytic practices for multidrug-resistant TB	2
Digital adherence technology for TB: focus on livelihoods as well as lives	2
Immune response against TB and non-tuberculous mycobacterial pulmonary disease	2
Xpert Ultra in diagnosing extrapulmonary TB: accuracy and trace calls	2
Medicinal plant use and adherence problems to TB treatment	2
Ratios from full blood count as markers for TB diagnosis, treatment, prognosis: a systematic review	2
Mediastinal mycobacterial lymphadenitis and endoscopic ultrasound-guided needle aspiration techniques	2
Post-TB health and wellbeing	2
Health-related quality of life and its effect on TB treatment outcomes	2
Emphasis on post-TB lung disease and other sequelae of TB is good but a public health approach to TB is morally ambitious	2
Low-cost air quality portable sensors and their potential use in respiratory health	2
Minimal clinically important difference of the 6-min walking test in patients with asthma	2
Omadacycline enhances the in vitro activity of clofazimine against Mycobacterium abscessus	2
Differentiated TB care: Tamil Nadu’s achievements, plans and implications for national TB programmes	2
Scaling up shorter TB preventive treatment is long overdue	2
Post-TB bronchiectasis: clinical characteristics and microbiology	2
Assessment of asthma control in users of oral anti-asthma medications	2
The 100^th anniversary of bacille Calmette-Guérin (BCG) and the latest vaccines against COVID-19	2
Cost of TB services in the public and private sectors in Georgia (No 2)	2
Eosinophils in bronchiectasis: searching for a new endotype	2
Paediatric TB care in the United Kingdom	2
Concomitant pulmonary disease is common among patients with extrapulmonary TB	2
Treatment success among Myanmar migrants with TB in Thailand	2
First report of multidrug-resistant M. tuberculosis Beijing strain isolated from the indigenous population in Tunisia	2
User perspectives on the use of X-rays and computer-aided detection for TB	2
Disseminated TB: still being missed and misunderstood	2
Introduction of new drugs for drug-resistant TB in Iraq	2
Successes and challenges of latent TB screening and treatment in a high-prevalence US region	2
Best practices for the care of pregnant people living with TB	2
A comprehensive person-centred TB care model, from malnutrition to mental health	2
Factors associated with patient delay in the diagnosis of TB – a study of health-seeking behaviour	2
Launch of the IJTLD Clinical Standards for Lung Health	2
Tobacco cessation services in the Indian state of Uttarakhand	2
Laboratory costs of diagnosing TB in a high multidrug-resistant TB setting	2
Factors associated with referrals for directly observed treatment and unsuccessful treatment	2